πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9809588

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9808505

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial prot

The Board of Regents of the University of Texas System Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9808486

Administration of kynurenine depleting enzymes for tumor therapy

The Board of Regents of the University of Texas System Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9801863

Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells a

The Board of Regents of the University of Texas System Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9801944

Lipocationic polymers and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9801962

Radioactive nanoparticles and methods of making and using the same

The Board of Regents of the University of Texas System Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9795673

Treating macular degeneration using antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9790233

Compositions and methods of modulating 15-PGDH activity

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9790274

Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastas

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9790495

Antisense antibacterial compounds and methods

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9789096

Methods and compositions for selective and targeted cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9789116

Compositions and methods of modulating short-chain dehydrogenase activity

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9789131

Compounds and methods for treating neurological and cardiovascular conditions

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9783550

Highly potent inhibitors of porcupine

The Board of Regents of the University of Texas System Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9770504

Generating peptoid vaccines

The Board of Regents of the University of Texas System Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9770500

S-nitrosylation of glucosylating toxins and uses therefor

The Board of Regents of the University of Texas System Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9765099

STAT6 inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9757379

Inhibition of HIF-2Ξ± heterodimerization with HIF1Ξ² (ARNT)

The Board of Regents of the University of Texas System Β· Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9750849

Oxygen generating biomaterial

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9751970

Block copolymer and micelle compositions and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9744142

Formulations of volatile anesthetics and methods of use for reducing inflammation

The Board of Regents of the University of Texas System Β· Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9737512

Methods and compositions for treating chronic pain

The Board of Regents of the University of Texas System Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9732114

Compounds having anti-adhesive effects on cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9730894

Stabilized HME composition with small drug particles

The Board of Regents of the University of Texas System Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted